Trump Administration Launches $5B AI Initiative for Federal Research

The Trump administration has announced a $5bn initiative aimed at leveraging artificial intelligence to solve complex scientific challenges across the United States. The program, which involves 15 federal agencies, seeks to utilize AI to accelerate drug discovery, identify the root causes of chronic diseases, and develop more durable building materials.

A Multi-Agency AI Effort

The project will integrate resources from across the federal government, including the Departments of Energy, Health and Human Services, Defense, Transportation, and the Interior. According to Michael Kratsios, the chief technology adviser to Donald Trump, the White House is coordinating these agencies to create a unified effort focused on AI-driven scientific advancement.
To facilitate this work, scientists will gain access to specialized datasets, AI tools, and the Department of Energy’s supercomputing infrastructure. The initiative aims to leverage the vast stores of government-held data—ranging from patient health records to information on critical minerals and chemicals—to train AI models capable of generating predictions, identifying patterns, and automating complex scientific decision-making. Microsoft has also committed to supporting the effort by donating $40m in AI computing credits over a three-year period.

Overhauling Federal Research Funding

Beyond the $5bn initiative, the administration is moving to restructure how federal research is funded. A White House report authored by Kratsios outlines a shift in strategy that prioritizes support for individual scientists and AI development over traditional funding for universities. The report states that federal support for science must be "politically accountable," signaling a broader effort by the administration to exert more direct control over the allocation of research dollars.
This shift comes amid ongoing legal friction regarding federal grant distribution. While the administration has sought to redirect research funding, federal courts have previously intervened. In January, an appeals panel ruled that the administration could not cut National Institutes of Health grant funding to universities engaged in medical and scientific research. Despite these legal challenges, the administration's new policy framework aims to centralize oversight of how research capital is deployed, ensuring that government-backed scientific inquiry aligns with its broader strategic objectives.